Clinical Thyroidology®: Does the Addition of Low-Dose Methotrexate to Antithyroidal Drugs Improve Remission Rates in Graves’ Disease?

Home » Clinical Thyroidology®: Does the Addition of Low-Dose Methotrexate to Antithyroidal Drugs Improve Remission Rates in Graves’ Disease?

Does the Addition of Low-Dose Methotrexate to Antithyroidal Drugs Improve Remission Rates in Graves’ Disease?
Sana A. Ghaznavi

Thyroid News Information

• General Information/Press Room
• Current Thyroid News
• Announcements
• ATA-Medscape Collaboration
• Journal Press
• Partner Relations
• Public Health Statements

Thyroid Posts by Category

Thyroid Posts by Category Select Category ATA Leadership Perspectives on COVID-19 Basic Science Research Bioequivalence Clinical Thyroidology Clinical Thyroidology for the Public Corporate News Featured Friends of the ATA Goiter Graves’ Disease Hashimoto’s Thyroiditis Hyperthyroidism Hypothyroidism Iodine Deficiency Low Iodine Diet News Releases Nuclear Radiation | Thyroid Effects Past News Releases Pediatric Endocrinology | Childhood Head and Neck Irradiation Postpartum Thyroiditis Potassium Iodide (KI) Public Health Statements Radioactive Iodine Thyroid and Weight Thyroid Cancer Thyroid Disease and Complementary and Alternative Medicine Thyroid Disease and Pregnancy Thyroid Disease in the Older Patient Thyroid Eye Disease (TED) Thyroid Function Tests Thyroid Health Blog Thyroid Hormone Effect and Metabolism Thyroid Hormone Treatment Thyroid Journal Thyroid Nodules Thyroid Surgery Thyroiditis Translational Research VideoEndocrinology

ATA Resources

ATA Career Center